Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
Senate Bill 2004
115th Congress(2017-2018)
Combating the Opioid Epidemic Act
Introduced
Introduced
Introduced in Senate on Oct 25, 2017
Overview
Text
Introduced in Senate 
Oct 25, 2017
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in Senate(Oct 25, 2017)
Oct 25, 2017
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
S. 2004 (Introduced-in-Senate)


115th CONGRESS
1st Session
S. 2004


To increase funding for the State response to the opioid misuse crisis and to provide funding for research on addiction and pain related to the substance misuse crisis.

IN THE SENATE OF THE UNITED STATES

October 25, 2017

Mr. Casey (for himself, Mr. Markey, Ms. Hassan, Mr. Heinrich, Mrs. Shaheen, Mr. Kaine, Mrs. Feinstein, Ms. Klobuchar, Mr. Franken, Mr. King, Ms. Baldwin, Ms. Warren, Mr. Brown, Mr. Menendez, Ms. Harris, Mr. Udall, and Mr. Nelson) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

A BILL

To increase funding for the State response to the opioid misuse crisis and to provide funding for research on addiction and pain related to the substance misuse crisis.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Combating the Opioid Epidemic Act”.

SEC. 2. Additional funding for the State response.

(a) Funding.—Section 1003 of the 21st Century Cures Act (42 U.S.C. 290ee–3 note) is amended—

(1) in subsection (a), by striking “under subsection (b)” and inserting “under subsection (b)(3) and the appropriations under subsection (b)(4)”;

(2) in subsection (b), by adding at the end the following:

“(4) ADDITIONAL APPROPRIATIONS.—In addition to the amounts transferred to the Account under paragraph (2)(A), there are authorized to be appropriated, and there are appropriated, to the Secretary, out of monies in the Treasury not otherwise obligated, $4,474,800,000 for each of fiscal years 2018 through 2027, to carry out the grant program described in subsection (c). Such funds shall remain available until expended.”; and

(3) by striking subsection (f).

(b) Activities.—Section 1003(c)(1) of the 21st Century Cures Act (42 U.S.C. 290ee–3 note) is amended—

(1) by redesignating subparagraph (E) as subparagraph (G); and

(2) by inserting after subparagraph (D) the following:

“(E) Detection, surveillance, and treatment of co-occurring infections associated with the opioid epidemic, including hepatitis C and HIV.

“(F) Surveillance, data collection, and timely and consistent reporting on the number of opioid overdose deaths, including the incidence and prevalence of co-occurring infections and toxicology reporting on the number of deaths where fentanyl or other illicit opioid analogs were detected.”.

SEC. 3. Grants for research on addiction and pain.

(a) In general.—The Secretary of Health and Human Services (referred to in this section as the “Secretary”) shall use any funds appropriated under subsection (b) to award grants for the purpose of conducting research on addiction and pain related to substance misuse. The Secretary, acting through the Director of the National Institutes of Health, shall determine the amount of each grant awarded under this section.

(b) Appropriations.—There are authorized to be appropriated, and there are appropriated, to the Secretary, out of monies in the Treasury not otherwise obligated, $50,400,000 for each of fiscal years 2018 through 2022, to carry out the grant program described in subsection (a). Such funds shall remain available until expended.